Industrial and Medical Gases Nigeria Past Earnings Performance
Past criteria checks 4/6
Industrial and Medical Gases Nigeria has been growing earnings at an average annual rate of 38.5%, while the Chemicals industry saw earnings growing at 24.6% annually. Revenues have been growing at an average rate of 20.3% per year. Industrial and Medical Gases Nigeria's return on equity is 33.7%, and it has net margins of 23.1%.
Key information
38.5%
Earnings growth rate
37.4%
EPS growth rate
| Chemicals Industry Growth | 6.3% |
| Revenue growth rate | 20.3% |
| Return on equity | 33.7% |
| Net Margin | 23.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Industrial and Medical Gases Nigeria makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 8,020 | 1,856 | 2,560 | 0 |
| 30 Jun 24 | 6,985 | 2,074 | 2,364 | 0 |
| 31 Mar 24 | 6,329 | 1,696 | 2,257 | 0 |
| 31 Dec 23 | 6,065 | 853 | 2,068 | 0 |
| 30 Sep 23 | 5,753 | 653 | 1,794 | 0 |
| 30 Jun 23 | 5,686 | 505 | 1,700 | 0 |
| 31 Mar 23 | 5,515 | 457 | 1,613 | 0 |
| 31 Dec 22 | 5,339 | 448 | 1,618 | 0 |
| 30 Sep 22 | 4,754 | 409 | 1,611 | 0 |
| 30 Jun 22 | 4,307 | 472 | 1,529 | 0 |
| 31 Mar 22 | 4,049 | 438 | 1,506 | 0 |
| 31 Dec 21 | 3,699 | 372 | 1,323 | 0 |
| 30 Sep 21 | 3,582 | 415 | 1,248 | 0 |
| 30 Jun 21 | 3,466 | 328 | 1,196 | 0 |
| 31 Mar 21 | 3,124 | 246 | 1,056 | 0 |
| 31 Dec 20 | 3,171 | 292 | 1,151 | 0 |
| 30 Sep 20 | 3,253 | 284 | 1,118 | 0 |
| 30 Jun 20 | 3,066 | 241 | 1,077 | 0 |
| 31 Mar 20 | 3,144 | 939 | 1,182 | 0 |
| 31 Dec 19 | 3,070 | 216 | 1,156 | 0 |
| 30 Sep 19 | 3,012 | 264 | 1,049 | 0 |
| 30 Jun 19 | 2,981 | 318 | 1,069 | 0 |
| 31 Mar 19 | 2,991 | -305 | 1,021 | 0 |
| 31 Dec 18 | 2,870 | 358 | 969 | 0 |
| 30 Sep 18 | 2,848 | 235 | 943 | 0 |
| 30 Jun 18 | 2,724 | 245 | 868 | 0 |
| 31 Mar 18 | 2,595 | 223 | 784 | 0 |
| 31 Dec 17 | 2,545 | 234 | 765 | 0 |
| 30 Sep 17 | 2,284 | 383 | 860 | 0 |
| 30 Jun 17 | 2,247 | 200 | 862 | 0 |
| 31 Mar 17 | 2,094 | 101 | 811 | 0 |
| 31 Dec 16 | 1,984 | 76 | 780 | 0 |
| 30 Sep 16 | 1,872 | 13 | 671 | 0 |
| 30 Jun 16 | 1,883 | 99 | 670 | 0 |
| 31 Mar 16 | 1,935 | 102 | 676 | 0 |
| 31 Dec 15 | 1,988 | 121 | 732 | 0 |
| 30 Sep 15 | 2,132 | 109 | 873 | 0 |
| 30 Jun 15 | 2,203 | 155 | 899 | 0 |
| 31 Mar 15 | 2,198 | 210 | 952 | 0 |
| 31 Dec 14 | 2,213 | 227 | 937 | 0 |
| 30 Sep 14 | 2,143 | 182 | 931 | 0 |
| 30 Jun 14 | 2,016 | 188 | 1,311 | 0 |
| 31 Mar 14 | 2,075 | 233 | 1,064 | 0 |
| 31 Dec 13 | 2,092 | 263 | 849 | 0 |
Quality Earnings: IMG has a high level of non-cash earnings.
Growing Profit Margin: IMG's current net profit margins (23.1%) are higher than last year (11.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMG's earnings have grown significantly by 38.5% per year over the past 5 years.
Accelerating Growth: IMG's earnings growth over the past year (184.2%) exceeds its 5-year average (38.5% per year).
Earnings vs Industry: IMG earnings growth over the past year (184.2%) exceeded the Chemicals industry 16.2%.
Return on Equity
High ROE: Whilst IMG's Return on Equity (33.74%) is high, this metric is skewed due to their high level of debt.